Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (390)	4/25/1998 9:01:00 AM
From: BDR	Read Replies (1) \| Respond to of 1016

I am talking about a short term long position, not a religious conversion to the "put all my 401k money long VVUS until I retire" type of fervor. I have said before that one can make money trading this (and ZONA) both ways, but I wouldn't buy and hold forever (or even for a month). Die hard shorts, on the other hand, look at this rise as a gift and I think they will be proven right, too.

To: AlienTech who wrote (390)	4/25/1998 1:32:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 1016

AlienTech....First Mike D..now Dale..PaineWebber analyst and even Barrons today said "Anyone that has an effective drug therapy will have a nice niche" ....other potency drug's haven't given up the fight. IMO VVUS and PFE are both champs...just different weight divisions... the other companies aren't even ranked by the FDA boxing commission....Upjohn's Caverject injection is just a sparing partner...some of the others will never get in the ring.